Head and Neck Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Psychological and Psychiatric prOfile in Glioblastoma and Head and Neck Cancer
Conditions: Glioblastoma; Head and Neck Cancer Interventions: Other: Psychological Tests ' administration Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials

A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors
Conditions: Metastatic Tumor; Advanced Solid Tumor; Renal Cell Carcinoma; Ovarian Cancer; Cervix Cancer; Head and Neck Squamous Cell Carcinoma; Nasopharyngeal Carcinoma Interventions: Drug: CHT101 Sponsors: Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials

Using an End-of-life Conversation Game to Engage Patients With Cancer in Advance Care Planning: Phase 2
Conditions: Breast Cancer; Lung Cancer; Genito-Urinary Cancer; Colorectal Cancer; Gastric Cancer; Pancreatic Cancer; Liver Cancer; Head and Neck Cancer; Melanoma Interventions: Behavioral: Hello for Cancer game; Other: Table Topics game Sponsors: Milton S. Hershey Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Recurrent/Metastatic Head and Neck Cancer
Conditions: Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Interventions: Biological: Amivantamab; Biological: Pembrolizumab; Drug: Paclitaxel Sponsors: Janssen Research& Development, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer
Conditions: Advanced Solid Tumours; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Triple Negative Breast Neoplasms; Carcinoma, Renal Cell (Clear Cell Only); Esophageal Neoplasms; Stomach Neoplasms (Excluding Gastrointestinal Stromal Tumors); Uterine Cervical Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms Interventions: Drug: UCB4594 Sponsors: Cancer Research UK; UCB Biopharma SRL Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials

A Study of HB-202/HB-201 in People With Human Papilloma Virus 16-Positive Head and Neck Squamous Cell Cancer (HPV 16+ HNSCC)
Conditions: HPV16+ Squamous Cell Carcinoma Interventions: Drug: HB-200; Other: Placebo Sponsors: Memorial Sloan Kettering Cancer Center; Hookipa Biotech GmbH; Naveris Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials

Adverse Events for Free Flap Surgery in Head and Neck Cancer
Conditions: Surgical Flaps; Flap Failure Risk Factors; Hematoma Risk Factors; Thrombosis Risk Factors Interventions: Procedure: Free Flap surgery Sponsors: Kaohsiung Medical University; Kaohsiung Medical University Chung-Ho Memorial Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials

Tirelizumab in Combination With Carboplatin and Polymeric Micellar Paclitaxel for Neoadjuvant Therapy in cN+ HNSCC
Conditions: Head and Neck Squamous Cell Carcinoma; Head and Neck Cancer; HNSCC; Head Cancer Neck Interventions: Drug: Carboplatin; Drug: Tislelizumab; Drug: Polymeric Micellar Paclitaxel; Procedure: Surgical Resection of Primary +/- Neck Dissection; Radiation: Post-operative radiation therapy Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials

Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.
Conditions: Esophageal Neoplasms; Head and Neck Neoplasms; Gastrointestinal Neoplasms; Digestive System Diseases; Digestive System Neoplasms; Esophageal Diseases; Neoplasms by Site; Gastrointestinal Diseases; Neoplasms Interventions: Device: " BRAXX " Esophageal Brachytherapy Applicator.; Radiation: Add-on of intraluminal brachytherapy Sponsors: Taipei Veterans General Hospital, Taiwan Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials

Efficacy and Toxicity of Docetaxel as a Radiosenstizer in Head and Neck Cancer
Conditions: Head and Neck Cancer Interventions: Drug: Docetaxel Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials

CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers
Conditions: Cervical Cancer; Anal Cancer; Head and Neck Cancers; Other Solid Tumors Interventions: Drug: CRTE7A2-01 TCR-T cell therapy Sponsors: Corregene Biotechnology Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck
Conditions: Recurrent Squamous Cell Carcinoma of the Head and Neck; Metastatic Squamous Cell Carcinoma; Head and Neck Squamous Cell Carcinoma Interventions: Drug: INQOVI (decitabine and cedazuridine); Drug: Nivolumab Sponsors: Case Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials

Efficacy of N-acetylcysteine in Preventing Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients.
Conditions: Oral Mucositis (Ulcerative) Due to Radiation Interventions: Drug: N-Acetyl-Cysteine with Institutional standard care; Drug: Institutional standard care Sponsors: Mansoura University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials

De-Escalation Postoperative Radiotherapy for Oral Squamous Cell Carcinoma With pCR/MPR.
Conditions: De-escalated Radiotherapy; Head and Neck Cancer Interventions: Radiation: Continuous, hyperfractionated, accelerated radiotherapy(CHART) Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials

Simultaneous Care in Recurrent and/or Metastatic Head and Neck Cancer: the SupCare Study
Conditions: Head and Neck Neoplasms Interventions: Procedure: Early palliative care, integrated with the standard oncologic care (proactive approach); Procedure: Palliative care requested as needed, integrated with the standard oncologic care (reactive approach) Sponsors: European Organisation for Research and Treatment of Cancer - EORTC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials